Prairiewood Capital, LLC Anavex Life Sciences Corp. Transaction History
Prairiewood Capital, LLC
- $245 Million
- Q1 2025
A detailed history of Prairiewood Capital, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Prairiewood Capital, LLC holds 13,800 shares of AVXL stock, worth $131,100. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,800
Previous 20,800
33.65%
Holding current value
$131,100
Previous $223,000
47.09%
% of portfolio
0.05%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
192Shares Held
29.3MCall Options Held
894KPut Options Held
821K-
Black Rock Inc. New York, NY6.39MShares$60.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$44.5 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$22.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$17.8 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$10.8 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $740M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...